John Ashley is a serial entrepreneur with over 30 years in the medical device industry. He has served as a CEO and in executive positions at numerous medical device companies, including ReValve Med, CoAlign Interventions (acquired by Stryker), ANPA Medical, Fox Hollow Technologies (IPO and acquired by EV3), Sapphire Medical (acquired by Tornier), Primaeva Medical (acquired by Syneron), and Oratec Interventions (IPO and acquired by Smith & Nephew). These start-ups returned over $1.25B to investors. John is also an adviser to the Surgical Innovations program at UCSF, the Biomedical Engineering Department at the University of the Pacific, and a Venture Mentor with the MIT Northern CA Alumni. He currently serve as the CEO of DurVena, Inc., a fledging cardiovascular device start-up as well as serving on the Board of ROMTherapy and HeathROM corporations.